Checkpoint inhibitor
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for Checkpoint inhibitor, covering 2023-08-22 to 2026-02-19. Get the full timeline:
Most recent: Clinical Trial Update: PACIFIC: Primary Mediastinal Large B-cell Lymphoma Treated With Antibody Therapy, Checkpoint Inhibitor in Frontline With ImmunoChemotherapy [Phase 2]